Sam Moskowitz

Education

• Clinical and Postdoctoral Fellowship University of Washington (1997 — 2001)
• Internship and Residency University of Washington (1994 — 1997)
• Bachelor's degree Princeton University (1982 — 1986)

Companies

• Courtesy Staff Massachusetts General Hospital (2015)
• Lecturer Harvard Medical School (2015)
• Senior Medical Director Vertex Pharmaceuticals (2019 — 2022)
• Medical Director Vertex Pharmaceuticals (2015 — 2019)
• Pediatrician Massachusetts General Hospital (2014 — 2015)
• Associate Professor Harvard Medical School (2014 — 2015)
• Assistant Professor Harvard Medical School (2010 — 2014)
• Associate Pediatrician Massachusetts General Hospital (2009 — 2014)
• Assistant Professor University of Washington (2001 — 2009)

Publications & Presentations

PubMed

• Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous forand a Minimal Function Mutation: A P... Marcus A Mall, Rossa Brugha, Silvia Gartner, Julian Legg, Alexander Moeller, Pedro Mondejar-Lopez, Dario Prais, Tacjana Pressler, Felix Ratjen, Philippe Reix, Paul D R...> ;American journal of respiratory and critical care medicine. 2022 Jul 11
• Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-wee... Sivagurunathan Sutharsan, Edward F McKone, Damian G Downey, Jamie Duckers, Gordon MacGregor, Elizabeth Tullis, Eva Van Braeckel, Claire E Wainwright, Danie Watson, Nei...> ;The Lancet. Respiratory medicine. 2022 Mar 1 16 citations
• Triple Therapy for Cystic Fibrosis Phe508del -Gating and -Residual Function Genotypes. Peter J. Barry, Marcus A. Mall, Antonio Álvarez, Carla Colombo, Karin M. de Winter-de Groot, Isabelle Fajac, Kimberly Ann McBennett, Edward F. McKone, Bonnie W. Ramsey...> ;The New England Journal of Medicine. 2021 Aug 25

Grant Support

Polymyxin-Resistant Pseudomonas In CF Lung Infection National Institute Of Allergy And Infectious Diseases 2009–2010

Polymyxin-Resistant Pseudomonas In CF Lung Infection National Institute Of Allergy And Infectious Diseases 2007–2008

Standard Versus Biofilm Susceptibility Testing In Cystic Fibrosis (CF) National Center For Research Resources 2006

Influence Of ENAC Regulators On CF Lung Severity National Heart, Lung, And Blood Institute 2005–2006

Genetics Of Cystic Fibrosis Lung Sparing National Center For Research Resources 2004–2005

Host-Pathogen Interactions In Cystic Fibrosis National Heart, Lung, And Blood Institute 2001–2005

Genetics Of Cystic Fibrosis Lung Disease National Center For Research Resources 2004